메뉴 건너뛰기




Volumn 19, Issue 13, 2013, Pages 2432-2438

Chronic hyperuricemia, uric acid deposit and cardiovascular risk

Author keywords

Allopurinol; Cardiovascular risk; Febuxostat; Metabolic syndrome; Uric acid

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; BIOLOGICAL MARKER; CHOLESTEROL; FEBUXOSTAT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OXIPURINOL; PLACEBO; TRIACYLGLYCEROL; URATE; URIC ACID;

EID: 84877796255     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319130011     Document Type: Review
Times cited : (172)

References (37)
  • 1
    • 74849100586 scopus 로고    scopus 로고
    • Gout
    • Richette P, Bardin T. Gout. Lancet 2010; 375 (9711): 318-28.
    • (2010) Lancet , vol.375 , Issue.9711 , pp. 318-328
    • Richette, P.1    Bardin, T.2
  • 3
    • 1542376013 scopus 로고    scopus 로고
    • Uric acid and diet-insights into the epidemic of cardiovascular dis-ease
    • Johnson RJ, Rideout BA. Uric acid and diet-insights into the epidemic of cardiovascular dis-ease. N Engl J Med 2004; 350: 1071-4.
    • (2004) N Engl J Med , vol.350 , pp. 1071-1074
    • Johnson, R.J.1    Rideout, B.A.2
  • 4
    • 34548759135 scopus 로고    scopus 로고
    • Gout: An update
    • Eggebeen AT. Gout: an update. Am Fam Physician 2007; 76(6): 801-8.
    • (2007) Am Fam Physician , vol.76 , Issue.6 , pp. 801-808
    • Eggebeen, A.T.1
  • 5
  • 6
    • 34548759135 scopus 로고    scopus 로고
    • Gout: An update
    • Eggebeen AT. Gout: an update. Am Fam Physician 2007; 76(6): 801-8.
    • (2007) Am Fam Physician , vol.76 , Issue.6 , pp. 801-808
    • Eggebeen, A.T.1
  • 7
    • 0026592267 scopus 로고
    • Two independent mutational events in the loss of urate oxidase during hominoid evolution
    • Wu XW, Muzny DM, Lee CC, Caskey CT. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 1992; 34: 78-84.
    • (1992) J Mol Evol , vol.34 , pp. 78-84
    • Wu, X.W.1    Muzny, D.M.2    Lee, C.C.3    Caskey, C.T.4
  • 8
    • 0019787519 scopus 로고
    • Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: A hypothesis
    • Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-62.
    • (1981) Proc Natl Acad Sci USA , vol.78 , pp. 6858-6862
    • Ames, B.N.1    Cathcart, R.2    Schwiers, E.3    Hochstein, P.4
  • 9
    • 54949100735 scopus 로고    scopus 로고
    • Uric Acid and Cardiovascular Risk
    • Feig DI, Kang DH, Johnson RJ. Uric Acid and Cardiovascular Risk. N Engl J Med 2008; 359(17): 1811-21.
    • (2008) N Engl J Med , vol.359 , Issue.17 , pp. 1811-1821
    • Feig, D.I.1    Kang, D.H.2    Johnson, R.J.3
  • 10
    • 0023634573 scopus 로고
    • Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study
    • Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987; 82: 421-6.
    • (1987) Am J Med , vol.82 , pp. 421-426
    • Campion, E.W.1    Glynn, R.J.2    DeLabry, L.O.3
  • 13
    • 80053497428 scopus 로고    scopus 로고
    • Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
    • Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63(10): 3136-41.
    • (2011) Arthritis Rheum , vol.63 , Issue.10 , pp. 3136-3141
    • Zhu, Y.1    Pandya, B.J.2    Choi, H.K.3
  • 15
    • 34548142983 scopus 로고    scopus 로고
    • Independent impact of gout on mortality and risk for coronary heart disease
    • Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116: 894-900.
    • (2007) Circulation , vol.116 , pp. 894-900
    • Choi, H.K.1    Curhan, G.2
  • 16
    • 33846998296 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey
    • Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007; 57: 109-15.
    • (2007) Arthritis Rheum , vol.57 , pp. 109-115
    • Choi, H.K.1    Ford, E.S.2    Li, C.3    Curhan, G.4
  • 18
    • 44349151051 scopus 로고    scopus 로고
    • Long-term cardiovascular mortality among middle-aged men with gout
    • MRFIT Research Group
    • Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH. MRFIT Research Group. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008; 168: 1104-10.
    • (2008) Arch Intern Med , vol.168 , pp. 1104-1110
    • Krishnan, E.1    Svendsen, K.2    Neaton, J.D.3    Grandits, G.4    Kuller, L.H.5
  • 19
    • 0038119701 scopus 로고    scopus 로고
    • Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
    • Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41(6): 1183-90.
    • (2003) Hypertension , vol.41 , Issue.6 , pp. 1183-1190
    • Johnson, R.J.1    Kang, D.H.2    Feig, D.3
  • 20
    • 0035993006 scopus 로고    scopus 로고
    • Gout, diet, and the insulin resistance syndrome
    • Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002; 29: 1350-5.
    • (2002) J Rheumatol , vol.29 , pp. 1350-1355
    • Fam, A.G.1
  • 21
    • 0033936010 scopus 로고    scopus 로고
    • Beneficial effects of weight loss associated with moderate calorie/ carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: A pilot study
    • Dessein PH, Shipton EA, Stanwix AE, Joffe BI, Ramokgadi J. Beneficial effects of weight loss associated with moderate calorie/ carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 2000; 59: 539-43.
    • (2000) Ann Rheum Dis , vol.59 , pp. 539-543
    • Dessein, P.H.1    Shipton, E.A.2    Stanwix, A.E.3    Joffe, B.I.4    Ramokgadi, J.5
  • 22
    • 0026325211 scopus 로고
    • Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration
    • Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991; 266(21): 3008-11.
    • (1991) JAMA , vol.266 , Issue.21 , pp. 3008-3011
    • Facchini, F.1    Chen, Y.D.2    Hollenbeck, C.B.3    Reaven, G.M.4
  • 23
    • 0030882289 scopus 로고    scopus 로고
    • Close correlation between visceral fat accumulation and uric acid metabolism in healthy men
    • Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 1997; 46 (10): 1162-5.
    • (1997) Metabolism , vol.46 , Issue.10 , pp. 1162-1165
    • Takahashi, S.1    Yamamoto, T.2    Tsutsumi, Z.3    Moriwaki, Y.4    Yamakita, J.5    Higashino, K.6
  • 24
    • 33751087771 scopus 로고    scopus 로고
    • Uric acid and the development of hypertension: The normative aging study
    • Perlstein TS, Gumieniak O, Williams GH, et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006; 48(6): 1031-6.
    • (2006) Hypertension , vol.48 , Issue.6 , pp. 1031-1036
    • Perlstein, T.S.1    Gumieniak, O.2    Williams, G.H.3
  • 25
    • 34447318846 scopus 로고    scopus 로고
    • Association between serum uric acid and prehypertension among US adults
    • Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens 2007; 25: 1583-9.
    • (2007) J Hypertens , vol.25 , pp. 1583-1589
    • Syamala, S.1    Li, J.2    Shankar, A.3
  • 26
    • 33646149386 scopus 로고    scopus 로고
    • Serum uric acid is associated with microal-buminuria in prehypertension
    • Lee JAE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microal-buminuria in prehypertension. Hypertension 2006; 47: 962-7.
    • (2006) Hypertension , vol.47 , pp. 962-967
    • Lee, J.A.E.1    Kim, Y.G.2    Choi, Y.H.3    Huh, W.4    Kim, D.J.5    Oh, H.Y.6
  • 28
    • 39749157632 scopus 로고    scopus 로고
    • Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study
    • Loachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008; 58(2): 623-30.
    • (2008) Arthritis Rheum , vol.58 , Issue.2 , pp. 623-630
    • Loachimescu, A.G.1    Brennan, D.M.2    Hoar, B.M.3    Hazen, S.L.4    Hoogwerf, B.J.5
  • 29
    • 84859792790 scopus 로고    scopus 로고
    • Prognostic Value of Uric Acid in Patients With Acute Coronary Syndromes
    • Feb 9. [Epub ahead of print]
    • Ndrepepa G, Braun S, Haase HU, et al. Prognostic Value of Uric Acid in Patients With Acute Coronary Syndromes. Am J Cardiol 2012 Feb 9. [Epub ahead of print]
    • (2012) Am J Cardiol
    • Ndrepepa, G.1    Braun, S.2    Haase, H.U.3
  • 30
    • 33748608331 scopus 로고    scopus 로고
    • EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
    • Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1312-24.
    • (2006) Ann Rheum Dis , vol.65 , pp. 1312-1324
    • Zhang, W.1    Doherty, M.2    Bardin, T.3
  • 31
    • 75149194057 scopus 로고    scopus 로고
    • Update on gout: New therapeutic strategies and options
    • Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 2010; 6(1): 30-8.
    • (2010) Nat Rev Rheumatol , vol.6 , Issue.1 , pp. 30-38
    • Terkeltaub, R.1
  • 32
    • 28944437578 scopus 로고    scopus 로고
    • Febuxostat compared with allopurinol in patients with hyperuricemia and gout
    • Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353: 2450-61.
    • (2005) N Engl J Med , vol.353 , pp. 2450-2461
    • Becker, M.A.1    Schumacher Jr., H.R.2    Wortmann, R.L.3
  • 33
    • 56049101851 scopus 로고    scopus 로고
    • Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
    • Schumacher HR Jr, Becker MA, Wortmann RL, et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum 2008; 59: 1540-8.
    • (2008) Arthritis Rheum , vol.59 , pp. 1540-1548
    • Schumacher Jr., H.R.1    Becker, M.A.2    Wortmann, R.L.3
  • 34
    • 77953729446 scopus 로고    scopus 로고
    • The uratelowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: The CONFIRMS trial
    • Becker MA, Schumacher HR, Espinoza LR, et al. The uratelowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Research & Therapy 2010; 12: R63.
    • (2010) Arthritis Research & Therapy , vol.12
    • Becker, M.A.1    Schumacher, H.R.2    Espinoza, L.R.3
  • 35
    • 74549197894 scopus 로고    scopus 로고
    • Febuxostat: A selective xanthineoxidase/ xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout
    • Ernst ME, Fravel MA. Febuxostat: a selective xanthineoxidase/ xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout. Clin Ther 2009; 31(11): 2503-18.
    • (2009) Clin Ther , vol.31 , Issue.11 , pp. 2503-2518
    • Ernst, M.E.1    Fravel, M.A.2
  • 36
    • 47749120633 scopus 로고    scopus 로고
    • Therapeutic challenges in the management of gout in the elderly
    • Singh H, Torralba KD. Therapeutic challenges in the management of gout in the elderly. Geriatrics 2008; 63(7): 13-8.
    • (2008) Geriatrics , vol.63 , Issue.7 , pp. 13-18
    • Singh, H.1    Torralba, K.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.